ANDREAS ANTON;WACKER CHEMIE AG;DANIELA KATHMANN;ANTJE PARTHIER;HEIKO PULTKE;SUSAN LOREY;BERNHARD JANOWSKI
发明人:
申请号：
IL23313714
公开号：
IL233137D0
申请日:
2014.06.15
申请国别(地区):
IL
年份:
2014
代理人:
摘要：
The present invention relates to a proNGF mutant and to uses thereof, in particular the use of a proNGF mutant for producing human beta-NGF. The present invention discloses a method of preparing a biologically active human beta-NGF from an inactive insoluble proNGF mutant. A proNGF mutant of the invention is substituted by any amino acid but not Arg or Lys at the native protease cleavage site R 1 SK 3 R 4 at least at positions R 1 and K 3 corresponding to positions 101 and 103 of the human wildtype proNGF sequence.
